Fig. 3. Adverse events in comparison of short-term milrinone infusion with standard medical therapy, from the OPTIME-CHF trial.41
fib = fibrillation; MI = myocardial infarction
Reproduced with permission from: Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287(12):1541–7.41